Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529214 · ClinicalTrials.gov registry record · NA
An Evaluation of the Team Birth Project
A NA study of Pregnancy Complications and Cesarean Section Complications, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- NA
- Development phase
- 5,217
- Enrollment target
- 4
- Study locations
NCT03529214: Completed NA study of Pregnancy Complications and Cesarean Section Complications, sponsored by Harvard School of Public Health (HSPH).
NCT03529214 is a NA study of Pregnancy Complications and Cesarean Section Complications that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 5,217 participants, above the 3,657-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (43% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03529214, a NA study of Pregnancy Complications and Cesarean Section Complications, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- NA
- Development phase
- 5,217 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the feasibility of a pilot project to improve communication and teamwork and to increase vaginal delivery rates at hospital in the United States
Primary Outcome
At the project midline, percent of clinicians (physicians, midwives, and nurses) who would definitely or probably recommend the Team Birth project tools for use in other labor and delivery units.
Conditions Studied
Interventions
- BEHAVIORAL Exposed study site
Study Locations (4)
Washington
- Overlake Medical Center - Bellevue
- EvergreenHealth Medical Center - Kirkland
Massachusetts
- South Shore Hospital - Weymouth
Oklahoma
- Saint Francis Hospital - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,217 participants |
| Start Date | 2018-05-29 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03529214 record still lists
NCT03529214 is an interventional study that assigns participants to a tested intervention. Its 5,217 participants enrollment target places it among the larger protocols in the corpus, above the 3,657-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (43% higher).
The record links to 4 conditions, with Pregnancy Complications appearing as the primary indexed condition, and to 1 intervention - of which Exposed study site is the first listed.
NCT03529214 reports a single indexed study location in Washington, Massachusetts, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03529214 about?
NCT03529214 is a clinical study titled "An Evaluation of the Team Birth Project". The purpose of this study is to evaluate the feasibility of a pilot project to improve communication and teamwork and to increase vaginal delivery rates at hospital in the United States
What is the current status of trial NCT03529214?
This trial is currently completed. It is a NA study. The enrollment target is 5,217 participants. The study started on 2018-05-29. Estimated completion is 2019-12-31.
What conditions does trial NCT03529214 study?
This clinical trial studies the following conditions: Pregnancy Complications, Cesarean Section Complications, Maternal Complication of Pregnancy, Communication, Multidisciplinary.
What interventions are being tested in trial NCT03529214?
The interventions under investigation include: Exposed study site (BEHAVIORAL).
Who is sponsoring clinical trial NCT03529214?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03529214 being conducted?
This trial has 4 study locations across Massachusetts, Oklahoma, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03529214's enrollment target sits among peer trials
5,217 5th of 39 higher than 35 of 39 other Pregnancy Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Melanated Group Midwifery Care (MGMC)
RECRUITING · NA
-
Sleep Behaviors in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI